Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | Sep 30, 2025 | Sep 30, 2024 |
|---|---|---|
| Revenue | 5m | 7m |
| Research and development | 38m | 42m |
| Selling, general and administrative | 14m | 11m |
| Operating expenses | 51m | 53m |
| Operating income | −51m | −53m |
| Pre-tax income | — | −43m |
| Net income | −46m | −43m |
| Earnings per share | −0.54 | −0.52 |
| Earnings per share, diluted | −0.54 | −0.52 |
| Weighted average shares | 85m | 83m |
| Weighted average shares, diluted | 85m | 83m |
| Metric | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 132m | 103m | 101m | 116m | 121m | 132m | 139m | 139m |
| Total assets | 133m | 104m | 102m |
| Metric | Sep 30, 2025 | Sep 30, 2024 |
|---|---|---|
| Operating cash flow | −39m | −31m |
| Share-based compensation | 12m | 9m |
| Financing cash flow | 9m | 12m |
Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)
| 117m |
| 124m |
| 136m |
| 142m |
| — |
| Total liabilities | 6m | 9m | 11m | 17m | 13m | 15m | 12m | — |
| Equity | 127m | 95m | 91m | 100m | 111m | 120m | 130m | 135m |
| Shares outstanding | 93m | 87m | 85m | 85m | 85m | 85m | 85m | — |
| Shares issued | 93m | 87m | 85m | 85m | 85m | 85m | 85m | — |